Other Non-Current Assets Narrative (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2020 USD ($)	Dec. 31, 2023 USD ($) payment royalty_payment	Dec. 31, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues			$ 50,583	$ 47,680
Number of guaranteed royalty payments | royalty_payment			8
License Agreement with Sunovion Pharmaceuticals, Inc.
Accounts, Notes, Loans and Financing Receivable [Line Items]
Minimum royalty receivable		$ 1,000	$ 1
Number of annual royalty payments receivable | payment			5
Royalty
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues			$ (989)
Royalty | License Agreement with Sunovion Pharmaceuticals, Inc.
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues	$ 8,000	$ 8